Clik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Plummets After Filing 10-Q
Arch Therapeutics Inc. (OTCBB:ARTH) lost 12.73% once the market had time to properly react to its latest 10-Q hitting the web. Truth be told, the company’s financials do not look all that horrible,...
View ArticleClik here to view.
Clinical Trial Delay Devastates Arch Therapeutics Inc (OTCBB:ARTH)
With the start of the month the stock of Arch Therapeutics Inc (OTCBB:ARTH) began to slowly lose positions on the chart. The decline was far from alarming though as the daily losses remained minimal....
View ArticleClik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Is Still Hesitant
Arch Therapeutics Inc. (OTCBB:ARTH) barely moved in Friday’s session – and it doesn’t look like today will be any different in that respect. ARTH hasn’t really seen a lot of trading since the crash...
View ArticleClik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Stumbles Hard
Arch Therapeutics Inc. (OTCBB:ARTH) lost 12.50% of its market value yesterday, on a heavy dollar volume, in spite of the lack of developments surrounding the company. Since there are no news, filings...
View ArticleClik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Is Still Crashing
Arch Therapeutics Inc. (OTCBB:ARTH) tanked in double digits for a second day in a row yesterday, losing 10.48% of its market value on a dollar volume of nearly half a million dollars. Let’s have a look...
View ArticleClik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Makes Awesome Announcement
Arch Therapeutics Inc. (OTCBB:ARTH) added 40.80% to its market value yesterday, after its new press release hit the web and drove investors into a fit of frenzied buying. And who can really blame...
View ArticleClik here to view.
Arch Therapeutics Inc. (OTCBB:ARTH) Couldn’t Retain Its Gains
Arch Therapeutics Inc. (OTCBB:ARTH) managed a pretty spectacular 40% jump on Tuesday, but unfortunately for its supporters, the gains made back then proved unretainable. Why? As we discussed when the...
View ArticleClik here to view.
Arch Therapeutics Inc (OTCBB:ARTH) Submits Its Quarterly Report
After over three weeks of underwhelming chart performance the stock of Arch Therapeutics Inc (OTCBB:ARTH) is once again showing its ability to make huge jumps up the chart. Yesterday the ticker...
View ArticleClik here to view.
Arch Therapeutics Inc (OTCBB:ARTH) Corrects
At the end of last week the stock of Arch Therapeutics Inc (OTCBB:ARTH) suffered a minor correction of a little over 2%, on a volume of 3.47 million traded shares. This week isn’t starting any better...
View ArticleClik here to view.
Arch Therapeutics Inc (OTCMKTS:ARTH) Accelerates Its Climb
Yesterday the stock of Arch Therapeutics Inc (OTCMKTS:ARTH) gained even more momentum and as a result surged up the chart by more than 10%, climbing to a close at $0.474 per share. The increase in...
View Article
